
Open
SectorHealthcare
36 -3.49
24h
Min
35.2
Max
37.43
| Income | 699K -39M | 
|---|---|
| Sales | -5.5M 22M | 
| Profit margin | -173.517 | 
| Employees | 136 | 
| EBITDA | 9.2M -18M | 
| Recommendations | Strong Buy | 
|---|---|
| 12 Months Forecast | +79.96% upside | 
| Next Earnings | 3 lis 2025 | 
|---|
| Market Cap | 300M 1B | 
|---|---|
| Previous open | 39.49 | 
| Previous close | 36 | 
By Acuity
50%
50%
168 / 373 Ranking in Healthcare
By Trading Central
Confidence
Strong Bearish Evidence
Wyniki osiągnięte w przeszłości nie są gwarantem przyszłych wyników.
Price change
By TipRanks
12 Months Forecast
Average 65 USD 79.96%
High 90 USD
Low 20 USD
Based on 12 Wall Street analysts offering 12 month price targets forAnaptysBio Inc - Dist in the last 3 months.
By Acuity
News Sentiment
Neutral
Volatility
Below average
News Volume (RCV)
Below average
Selling and administration expenses
Operating expenses
Pre-tax profit
Sales
Cost of sales
Gross profit on sales
Interest expense on debt
EBITDA
Operating profit
$